BX Swiss TOP 30 CHF
1.376,73
PKT
-7,97
PKT
-0,58
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Givaudan Sell | UBS AG | |
| 13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.04.23 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 06.04.23 | Zurich Insurance Buy | UBS AG | |
| 06.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 05.04.23 | Richemont Buy | UBS AG | |
| 05.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 05.04.23 | Richemont Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | Nestlé Market-Perform | Bernstein Research | |
| 05.04.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.04.23 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 05.04.23 | Nestlé Market-Perform | Bernstein Research | |
| 03.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 03.04.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 03.04.23 | Zurich Insurance Overweight | Barclays Capital | |
| 30.03.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 30.03.23 | Givaudan Underweight | Barclays Capital | |
| 29.03.23 | UBS Overweight | JP Morgan Chase & Co. | |
| 29.03.23 | Givaudan Sell | UBS AG | |
| 29.03.23 | Nestlé Buy | UBS AG | |
| 29.03.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 29.03.23 | UBS Sector Perform | RBC Capital Markets | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Givaudan Hold | Deutsche Bank AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 27.03.23 | Givaudan Underperform | Jefferies & Company Inc. | |
| 27.03.23 | Nestlé Neutral | Credit Suisse Group | |
| 27.03.23 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 27.03.23 | Roche Equal Weight | Barclays Capital | |
| 27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
| 24.03.23 | UBS Hold | Jefferies & Company Inc. |